7 news items
Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
FENC
15 May 24
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $20 to $17.
HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $15
FENC
15 May 24
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $18 to $15.
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AGYS
AKYA
ALC
14 May 24
% to $2.22 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $11.5 to $3.75.
Akoya
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
FENC
14 May 24
targeted markets, revenues will not be sufficient to fund further development and clinical studies, our ability to obtain necessary capital when needed
HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $18
FENC
4 Apr 24
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $17 to $18.
abb7tmbsbqsjoe8ctvf v1p0
FENC
18 Mar 24
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $17 to $18.
h36 1d1wp9d
FENC
17 Mar 24
to penetrate one or more targeted markets, revenues will not be sufficient to fund further development and clinical studies, our ability to obtain
- Prev
- 1
- Next